Perfil
Mr. Dalen Meeter is a Chief Financial Officer at Aspen Neuroscience, Inc. Mr. Meeter was previously employed as a Chief Financial & Accounting Officer by Singular Genomics Systems, Inc. and a Senior Director-Finance by Illumina, Inc. He received his undergraduate degree from the University of California, Santa Barbara and an MBA from USC Marshall School of Business.
Cargos activos de Dalen Meeter
| Empresas | Cargo | Inicio |
|---|---|---|
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Director Financiero/CFO | 10/03/2025 |
Antiguos cargos conocidos de Dalen Meeter.
| Empresas | Cargo | Fin |
|---|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Director Financiero/CFO | 21/02/2025 |
| ILLUMINA, INC. | Director Financiero/CFO | 06/01/2017 |
Formación de Dalen Meeter.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
- Bolsa de valores
- Insiders
- Dalen Meeter
















